Clinical Trial Update: Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration. [Phase 4]

View source ↗

Summary

Phase 4 efficacy study evaluating ranibizumab for age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | Conditions: Macular Degeneration | Phase 4 | Status: COMPLETED